A deficiency or absence of FIBRINOGEN in the blood.
Approved for this indication (1)
Phase 4 trials (1)
Phase 3 trials (1)
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (1)